Ipamorelin 10mg

Ipamorelin

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue that has been extensively investigated for its ability to stimulate the release of growth hormone (GH). As a ghrelin receptor agonist, Ipamorelin interacts with the growth hormone secretagogue receptor (GHS-R) and has been studied for its effects on growth hormone secretion and related physiological pathways.

Unlike non-selective growth hormone secretagogues, Ipamorelin has been investigated for its relatively selective activity toward growth hormone release, with research examining its effects on GH secretion while producing comparatively limited activity on other hormones such as cortisol and prolactin. These characteristics have made Ipamorelin an important research peptide for investigating growth hormone physiology, endocrine signaling, metabolism, and tissue-related processes.

---

Overview

Ipamorelin is a five-amino-acid peptide belonging to the growth hormone secretagogue class. Its mechanism of action involves activation of the growth hormone secretagogue receptor, which stimulates the pituitary release of endogenous growth hormone. Because of this selective activity, Ipamorelin has been widely used in research investigating the regulation of GH secretion and the physiological effects associated with growth hormone signaling.

Research involving Ipamorelin has examined its relationship with growth hormone release, IGF-1 signaling, tissue repair pathways, metabolism, and other physiological processes influenced by the GH axis. Experimental studies have also investigated its potential effects in different models of tissue recovery and metabolic regulation, although these applications remain subjects of scientific investigation.

Chemical Makeup

• Molecular Formula: C38H49N9O5
• Molecular Weight: 711.86 g/mol
• Other Known Titles: Ipamorelin, NNC 26-0161

---

Research Studies and Clinical Trials

Ipamorelin and Growth Hormone Secretion

The primary area of Ipamorelin research involves stimulation of endogenous growth hormone release. Experimental studies have demonstrated that Ipamorelin can activate growth hormone secretagogue receptors and promote pulsatile GH secretion. Researchers continue to investigate how this selective secretagogue activity influences the regulation of the hypothalamic-pituitary-growth hormone axis.

Growth Hormone and IGF-1 Research

Growth hormone signaling is closely associated with downstream production of insulin-like growth factor-1 (IGF-1), which participates in numerous biological processes involving growth, metabolism, and tissue physiology. Ipamorelin research has therefore examined changes in GH and IGF-1 signaling to better understand how selective growth hormone secretagogues influence endocrine pathways.

Endocrine Selectivity Research

A notable characteristic of Ipamorelin is its research profile regarding endocrine selectivity. Studies have investigated its ability to stimulate GH release without producing the same degree of cortisol and prolactin elevation associated with some earlier growth hormone secretagogues. This selectivity has contributed to continued interest in Ipamorelin as a research tool for studying the GH secretagogue receptor.

Metabolic Research

Growth hormone has broad effects on lipid, glucose, and protein metabolism, making the GH axis an important area of metabolic research. Investigators have studied growth hormone secretagogues such as Ipamorelin to better understand how modulation of GH secretion may influence energy metabolism, substrate utilization, and related physiological pathways.

Tissue and Cellular Research

Research has also examined the broader biological effects associated with growth hormone signaling, including processes involved in tissue maintenance and cellular responses. Experimental models have investigated the relationship between GH-related pathways and mechanisms such as protein synthesis, cell proliferation, and tissue recovery. These areas remain under active investigation and should not be interpreted as established therapeutic applications of Ipamorelin.

Growth Hormone Secretagogue Research

Ipamorelin provides researchers with a selective model for studying ghrelin receptor and growth hormone secretagogue signaling. Continued research is evaluating how activation of these pathways influences endocrine regulation, metabolism, and other physiological processes. Its defined peptide structure and selective pharmacological profile have contributed to its use as a research compound in studies of the growth hormone axis.

---

Disclaimer: This Ipamorelin product is intended for laboratory and research purposes only. It is not approved by the FDA or other major health authorities for therapeutic or clinical use. This description is provided for informational purposes based on current scientific research and does not constitute medical advice.